pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·17h ago·1 min read
save

HHS unveils new vaccine injury surveillance plan with NIH clinic and reporting reimbursements

Oct 8, 2026·read at BioPharma Dive ↗RegulatoryNeutral

The Department of Health and Human Services announced a comprehensive initiative to improve monitoring of vaccine-related injuries.

The plan includes opening a new clinic at the National Institutes of Health in Bethesda, Maryland, where researchers will study health problems reported after immunization.

It also adds an updated reporting system and offers reimbursements to physicians who submit suspected vaccine side-effect reports, aiming to gather better evidence and improve patient outcomes.

The effort is being led by HHS Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “HHS launches new plan to strengthen vaccine injury research, reporting”

read at BioPharma Dive ↗
678 words · retrieved 26m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health2Ultragenyx Pharmaceutical Inc.
topics
Vaccine23Vaccines14Rare Disease

related stories

  • Sep 29Why MAHA wants to make health data much more accessibleSTAT
  • Sep 25Federal judge rolls back landmark disability protectionsSTAT
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Jun 4STAT+: RFK Jr.’s second year: Vacancies, not vaccinesSTAT